Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
What: Opko Health Inc.
So what: This unprofitable company has negative operating cash flows of about $50 million annually. Opko plans to use the funds for general corporate purposes such as R&D, clinical trials, and acquiring new technologies and businesses.
Now what: The company is likely hoping that recent market strength is an opportunity to raise additional capital. Revenue has been stagnate at $7.5 million to $8 million per quarter over the last year, suggesting that new products are needed to drive growth. Unless there is a big increase in revenue and/or severe cost cutting, the losses will continue, and Opko will eventually need more cash just to survive.
Interested in more info on Opko? Add it to your watchlist here.
Fool contributor Cindy Johnson does not own shares of any company named above. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.